The level of miR-21–3p in the tumor was prominently increased after anti-PD-1 antibody treatment (figure 2C), in keeping with the increase of IFN-γ in tumor-infiltrating CD8+ T cells (figure 2D). The gene discussed is PDCD1; the disease is neoplasm.